ResApp Health Limited (RAP:ASX) Investor Relations Material

Overview

ResApp Health Limited, a digital healthcare solutions developer based in Brisbane, Australia, focuses on assisting healthcare professionals and patients with respiratory diseases. The company uses sound technology for diagnosis and offers ResAppDx, a smartphone-based diagnostic test used in emergency departments, telehealth, and primary care markets. Additionally, ResApp offers SleepCheck, a mobile application for self-assessment and diagnosis of sleep apnea. The company has a joint development and pilot agreement with Medgate AG, to test its smartphone-based diagnostic tests. ResApp Health Limited was previously known as Narhex Life Sciences Limited and has been in operation since 2000.

Frequently Asked Questions

What is ResApp Health Limited's ticker?

ResApp Health Limited's ticker is RAP

What exchange is ResApp Health Limited traded on?

The company's shares trade on the ASX stock exchange

Where are ResApp Health Limited's headquarters?

They are based in Brisbane, Australia

How many employees does ResApp Health Limited have?

There are 11-50 employees working at ResApp Health Limited

What is ResApp Health Limited's website?

It is https://www.resapphealth.com.au/

What type of sector is ResApp Health Limited?

ResApp Health Limited is in the Healthcare sector

What type of industry is ResApp Health Limited?

ResApp Health Limited is in the Healthcare Information Services industry

Who are ResApp Health Limited's peers and competitors?

The following five companies are ResApp Health Limited's industry peers:

- ResApp Health Limited

- Veradigm

- Progyny

- Torex Gold Resources

- PainChek Limited